Skip to content
Gujarat Inject (Kerala) logo

Gujarat Inject (Kerala)

524238 BSE
₹11.16

Close ·

P/E
55.80
View as Markdown
MCP
Close 3 Nov 2026 ₹11.16 +8.67 +348% 1Y
Start ₹2.49

Key Fundamentals

MicrocapPharmaceuticalsHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
22.90%
Debt to Equity
0.00
EPS (TTM)
₹0.20
Book Value
₹0.81
Market Cap
—
P/E (TTM)
55.80
P/B
13.78
ROE
16.60%
Dividend Yield
0.00%
EBITDA
₹2.50 Cr
52W High
₹14.30
52W Low
₹2.32

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

53 Average

Data confidence 95/100

Category scores

Quality
65
Good
Returns, margins, earnings quality 22% weight
Valuation
22
Poor
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
52
Average
Solvency, leverage, coverage 9% weight
Momentum
69
Strong
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Debtor days have improved from 130 to 63.8 days.

Weaknesses

2
  • Stock is trading at 11.3 times its book value
  • Company has a low return on equity of 12.1% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish4312
OscillatorsBearish432
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
66.76
Neutral
MACD (12,26,9)
0.34
Bullish
SMA (50)
10.20
Bullish
SMA (200)
9.47
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+111.79%
5Y+415.26%
3Y+497.81%
1Y+90.66%
TTM+151.68%

Net profit

Net profit growth by window
10Y−2.37%
5YTurned to profit
3Y+256.35%
1Y+77.45%
TTM+212.50%

Operating cash flow

Operating cash flow growth by window
10YZero base
5YTurned positive
3Y+651.49%
1YTurned positive
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+6.33 pp
5YTiny sales
3Y+223.98 pp
1Y+0.71 pp
TTM+2.93 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹1.57 Cr
Mar 2018₹0.00 Cr
Mar 2019₹0.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.01 Cr
Mar 2022₹0.02 Cr
Mar 2023₹0.17 Cr
Mar 2024₹5.79 Cr
Mar 2025₹19.05 Cr
Mar 2026₹36.32 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.01 Cr
Mar 2018−₹0.02 Cr
Mar 2019−₹0.01 Cr
Mar 2020₹0.00 Cr
Mar 2021−₹0.11 Cr
Mar 2022₹0.00 Cr
Mar 2023₹0.04 Cr
Mar 2024₹0.08 Cr
Mar 2025₹1.02 Cr
Mar 2026₹1.81 Cr

Quarterly Results

₹ Cr
524238 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.15
0
0.22
5.42
3.05
8.61
3.15
4.24
2.42
1.58
1.63
30.7
12.45
Expenses
0.11
0
0.25
5.37
2.88
8.07
2.87
4.15
2.32
1.55
1.72
28.43
10.76
Operating Profit
0.04
0
−0.03
0.05
0.17
0.54
0.28
0.09
0.1
0.03
−0.09
2.27
1.69
OPM %
26.67%
—
−13.64%
0.92%
5.57%
6.27%
8.89%
2.12%
4.13%
1.9%
−5.52%
7.39%
13.57%
Other Income
0
0.02
0.04
0
0
0.17
0
0.01
0
0.06
0.14
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.04
0.02
0.01
0.05
0.17
0.71
0.28
0.1
0.1
0.09
0.05
2.27
1.69
Tax %
25%
0%
0%
20%
23.53%
14.08%
25%
30%
20%
22.22%
20%
27.75%
26.04%
Net Profit
0.03
0.01
0
0.04
0.12
0.61
0.21
0.07
0.07
0.07
0.04
1.64
1.25
EPS (₹)
0.01
0
0
0
0.01
0.04
0.01
0
0
0
0
0.11
0.09

Profit & Loss

₹ Cr
524238 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0.02
1.57
0
0
0
0.01
0.02
0.17
5.79
19.05
36.32
46.36
Expenses
0
0.02
1.56
0.07
0.03
0.01
0.13
0.07
0.54
5.74
17.98
34.02
42.46
Operating Profit
0
0
0.01
−0.07
−0.03
−0.01
−0.12
−0.05
−0.37
0.05
1.07
2.3
3.9
OPM %
—
0%
0.64%
—
—
—
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
−250%
−217.65%
0.86%
5.62%
6.33%
8.41%
Other Income
0
2.3
0
0.05
0.02
0.01
0.01
0.05
0.43
0.06
0.18
0.2
0.2
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
2.3
0.01
−0.02
−0.01
0
−0.11
0
0.06
0.11
1.25
2.5
4.1
Tax %
—
0%
0%
0%
0%
—
0%
—
16.67%
18.18%
19.2%
27.6%
—
Net Profit
0
2.3
0.01
−0.02
−0.01
0
−0.11
0
0.04
0.08
1.02
1.81
3
EPS (₹)
0
0.47
0
0
0
0
−0.02
0
0.01
0.01
0.07
0.12
0.2
Div. Payout %
—
0%
0%
0%
0%
—
0%
—
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
524238 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.88
4.88
4.88
4.88
4.88
4.88
4.88
4.88
4.88
11.29
14.63
14.63
Reserves
−7.95
−5.64
−5.64
−5.66
−5.66
−5.66
−5.77
−5.76
−5.72
−2.75
−4.62
−2.81
Borrowings
2.86
0.56
0.57
0.59
0.59
0.59
0.69
0.73
0.61
0
0
0
Other Liabilities
0.38
0.36
0.2
0.21
0.2
0.2
0.22
0.22
0.53
0.15
1.94
24.85
Total Liabilities
0.17
0.16
0.01
0.02
0.01
0.01
0.02
0.07
0.3
8.69
11.95
36.67
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
20.76
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.17
0.16
0.01
0.02
0.01
0.01
0.02
0.07
0.3
8.69
11.95
15.91
Total Assets
0.17
0.16
0.01
0.02
0.01
0.01
0.02
0.07
0.3
8.69
11.95
36.67

Cash Flow

₹ Cr
524238 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
0
−0.01
0
0
−0.11
0
0.05
−6.03
−3.52
21.22
Investing
0
0
0
0
0
0
0
0
0
0
0.18
−20.57
Financing
0
0
0
0
0
0
0.1
0
0
8.88
0.45
0
Net Cash Flow
0
0
0
−0.01
0
0
0
0
0.05
2.86
−2.89
0.65
Free Cash Flow
0
0
0
−0.01
0
0
−0.11
0
0.05
−6.03
−3.52
0.46
CFO/OP
—
—
0
14
0
0
92
0
−16
−12,020
−307
953

Ratios

524238 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
0
0
—
—
—
0
0
0
188
138
63.81
Inventory Days
—
—
0
—
—
—
0
0
0
0
0
0
Cash Conversion Cycle
—
0
0
—
—
—
0
0
0
188
138
63.81
Working Capital Days
—
−8,395
−107
—
—
—
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
−9,490
−1,546
355
138
−140
ROCE %
—
—
—
—
—
—
—
—
—
2.65%
13.48%
22.9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gujarat Inject (Kerala) insights

57 extracted metrics across FY04–FY27.

Shareholding Pattern

As of Jun 2026

  • Public 88.56%
  • Others 11.44%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Gujarat Inject (Kerala)

What does Gujarat Inject (Kerala) Ltd do?
Gujarat Inject (Kerala) Ltd has discontinued its legacy pharmaceutical manufacturing operations and currently follows a trading -led business model transitioning towards renewable energy.
Where is Gujarat Inject (Kerala) Ltd (GUJINJEC) listed?
Gujarat Inject (Kerala) Ltd trades under code 524238 on the BSE.
Which sector does Gujarat Inject (Kerala) Ltd belong to?
Gujarat Inject (Kerala) Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the PE ratio of Gujarat Inject (Kerala) Ltd?
Gujarat Inject (Kerala) Ltd trades at a PE ratio of 55.80 as of 3 Nov 2026, on earnings per share of ₹0.2, against a book value of ₹0.81 per share.
What is the 52-week high and low of Gujarat Inject (Kerala) Ltd?
Over the last 52 weeks Gujarat Inject (Kerala) Ltd has traded between ₹2.32 and ₹14.3 as of 3 Nov 2026.
What is the Return on Equity (ROE) of Gujarat Inject (Kerala) Ltd?
Gujarat Inject (Kerala) Ltd reported a return on equity of 16.60%. Its debt-to-equity ratio is 0.00.

Company Information

Gujarat Inject (Kerala) Ltd has discontinued its legacy pharmaceutical manufacturing operations and currently follows a trading -led business model transitioning towards renewable energy. Its disclosed activities include supplying 600–620Wp solar-PV modules, investing in a 5MW solar project and evaluating thermal-energy-storage opportunities.

Website gujaratinject.com
Listed 1 Mar 2006
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524238.md for Gujarat Inject (Kerala) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month